GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $107,375,000 | +301.5% | 2,466,699 | +301.7% | 0.45% | +327.4% |
| Q1 2022 | $26,746,000 | -28.7% | 614,000 | -27.8% | 0.11% | -29.3% |
| Q4 2021 | $37,511,000 | +299.7% | 850,600 | +233.6% | 0.15% | +226.1% |
| Q4 2020 | $9,384,000 | +442.7% | 255,000 | +529.6% | 0.05% | +318.2% |
| Q3 2019 | $1,729,000 | -96.1% | 40,500 | -96.3% | 0.01% | -95.2% |
| Q2 2019 | $44,229,000 | +342.6% | 1,105,172 | +362.1% | 0.23% | +413.3% |
| Q1 2019 | $9,994,000 | -0.8% | 239,157 | -4.3% | 0.04% | +12.5% |
| Q2 2018 | $10,078,000 | -58.9% | 250,000 | -58.6% | 0.04% | -63.6% |
| Q3 2017 | $24,539,000 | +469.1% | 604,419 | +504.4% | 0.11% | +358.3% |
| Q2 2017 | $4,312,000 | +22.7% | 100,000 | +14.8% | 0.02% | -17.2% |
| Q4 2015 | $3,514,000 | – | 87,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |